Timeline
AIM Deal Timeline
Our capital markets practice covers all matters surrounding the introduction of companies to AIM, and we are the retained legal adviser for a number of listed companies across a variety of areas, including: technology, healthcare, infrastructure, leisure and retail.
Please get in touch for any capital markets related queries
Philip Lamb
Partner
27 October 2022
Leading global semiconductor designer and supplier
Advised Sondrel (Holdings) PLC on £48.1 million AIM Listing
Click here to read moreAugust 2022
Speciality biopharmaceutical company
Advised ImmuPharma with its placing of new ordinary shares raising £1.04 million
Click here to read moreMarch 2022
Developer of advanced clinical prognostics in organ transplant
Advised Verici Dx on a fundraise of over £10m
Click here to read moreDecember 2021
UK manufacturer of specialist products using printed circuit technology
Advised finnCap on the placing, subscription and open offer of Trackwise Design PLC.
December 2021
Advised SPARK Advisory Partners Limited and Oberon Investments Limited on the AIM listing of 4Global PLC, raising £4 million, by way of a placing and subscription
Click here to read moreOctober 2021
Agriculture technology business
Advised Light Science Technologies Holdings PLC (LSTH) on the admission to AIM and associated placing
Click here to read moreJuly 2021
Professional services firm
Advised finnCap and Canaccord Genuity Limited on a placing by K3 Capital Group PLC to raise gross proceeds of £10m to fund the acquisition of Knight Corporate Finance Group Limited and R&D Limited
Click here to read moreJune 2021
Leading provider of digital transformation services
Advised Strand Hanson and Oberon Investments as nominated adviser and broker on the AIM IPO of Silverbullet Data Services Group PLC
Click here to read more
March 2021
Dynamic junior exploration company
Advised on a fundraising for ARC Minerals PLC
March 2021
Global supplier of a disruptive refinery upgrading technology
Advised Quadrise Fuels International PLC on a placing and open offer of shares
Click here to read moreNovember 2020
Developer of advanced clinical diagnostics for organ transplants
Advised Verici Dx on their AIM IPO
Click here to read moreNovember 2020
Creator of award-winning immersive virtual reality solutions
Placing and subscription of shares
Click here to read moreNovember 2020
Specialist products using printed circuit technology
Advised finnCap on the fundraising, placing, subscription and open offer of Trackwise Design PLC
Click here to read moreOctober 2020
Telecommunications service provider
Advised finnCap on Fonix Mobile’s AIM IPO
Click here to read moreOctober 2020
International provider of integrated state of the art Laboratory Services and Products
Advised Source BioScience on their AIM IPO and placing
Click here to read moreSeptember 2020
Leading property management company
Advised Harwood Capital and BDB Nominee Company in connection with BDB Nominee’s recommended cash offer for HML Holdings PLC
Click here to read moreAugust 2020
Professional services firm
Advised finnCap in relation to a placing by K3 Capital Group PLC
Click here to read moreJune 2020
Pharmaceutical development company
Advised Immupharma PLC on the issue of unsecured convertible securities and associated options
Click here to read moreJune 2020
UK's market-leading independent energy and multi-utility services provider
Advised Harwood Capital with its proposed unsolicited tender offer for Fulcrum Utility Services
Click here to read moreMay 2020
Niche CRO pharmaceutical services company
Advised Arden Partners PLC and finnCap on a placing and subscription from institutional investors to raise funds. Dual-listing on AIM and Euronext Growth markets
Click here to read moreApril 2020
Manufacturer of next-generation carbon ceramic brake discs for the automotive and aircraft industries
Advised finnCap and Cantor Fitzgerald Europe as joint bookrunners in connection with a placing for Surface Transforms PLC
Click here to read moreMarch 2020
World leader in the development of Live Biotherapeutics
Advised N+1 Singer and Bryan Garnier & Co on a placing and subscription to raise £22 million for 4D Pharma PLC
January 2020
Niche CRO pharmaceutical services company
Fully underwritten open offer to shareholders
Click here to read moreDecember 2019
Leader in antibiotic innovation
Advised N+1 Singer on a placing and subscription to raise $50m for Summit Therapeutics PLC
Click here to read moreSeptember 2019
Specialist electronic components manufacturing company
Advised Specialist Components Limited on its all cash recommended takeover by way of scheme of arrangement of APC Technology Group PLC
Click here to read moreSeptember 2019
Global supplier of a disruptive refinery upgrading technology
Advised on its fully underwritten open offer to shareholders
July 2019
Founder and global leader in the new field of bioprognosis for kidney health
Advised Renalytix AI PLC on a placing to raise £14 million
Click here to read moreMarch 2019
Manufacturer of next-generation carbon ceramic brake discs for the automotive and aircraft industries
Advused finnCap and Cantor Fitzgerald Europe as joint bookrunners in connection with placing for Surface Transforms PLC
February 2019
Optical products company
Advised finnCap on a placing and retail offer via Primary Bid by Scientific Digital Imaging PLC to finance the acquisition of Graticules
January 2019
Sensor technology and equipment
Advised finnCap on a complex placing involving 5 separate admissions for Transense Technologies PLC
January 2019
Global supplier of a disruptive refinery upgrading technology
Advised Quadrise Fuels International PLC on their AIM IPO, placing of shares and open offer
August 2018
Specialist products using printed circuit technology
Advised Arden Partners as Nomad and Broker on Trackwise Design PLC’s AIM IPO and placing of shares
Click here to read moreJuly 2018
Creator of award-winning immersive virtual reality solutions
Advised WH Ireland and Shard Capital Partners LLP on Immotion Group’s AIM IPO and placing
May 2018
UK based software company
Adivsed Maestrano Group PLC on their AIM IPO
January 2018
Speciality Biopharmaceutical company
Advised on a fundraising, by way of a share subscription and placing
